Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |